Bunge Limited to Hold Extraordinary General Meeting of Shareholders - Seite 3

These risks and uncertainties also include such additional risk factors as are discussed in Bunge’s filings with the SEC, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and its subsequent filings and quarterly reports. Bunge cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Bunge undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.

Additional Information About the Transactions and Where to Find It

This communication does not constitute a solicitation of any vote or approval in respect of the proposed Redomestication and Acquisition involving Bunge, Viterra and the Sellers. In connection with the proposed Redomestication and Acquisition, Bunge filed with the U.S. Securities and Exchange Commission (the “SEC”) a definitive proxy statement. Beginning on August 7, 2023, Bunge mailed the definitive proxy statement to the shareholders of Bunge. INVESTORS AND SHAREHOLDERS OF BUNGE ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT BUNGE AND THE PROPOSED REDOMESTICATION AND ACQUISITION TRANSACTIONS. Investors may obtain a free copy of these materials at the SEC’s website at www.sec.gov or from Bunge at its website at https://investors.bunge.com.

Participants in the Solicitation

Bunge and certain of its directors, executive officers and other members of management and employees may be deemed to be participants in soliciting proxies from its shareholders in connection with the proposed Redomestication and Acquisition. Information regarding the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of Bunge’s shareholders in connection with the proposed Redomestication or Acquisition is set forth in Bunge’s definitive proxy statement for the EGM, which was filed with the SEC on August 7, 2023, at which the Redomestication and the Acquisition will be submitted for approval by Bunge’s shareholders. You may also find additional information about Bunge’s directors and executive officers in Bunge’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on February 24, 2023, Bunge’s definitive proxy statement for its 2023 annual meeting of shareholders, which was filed with the SEC on March 31, 2023 and in subsequently filed Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230814461761/en/

The Bunge Stock at the time of publication of the news with a raise of +0,63 % to 103,2EUR on Tradegate stock exchange (14. August 2023, 13:54 Uhr).